Innoveren Scientific Inc.
Innoveren Scientific Inc., a medical bioscience company that develops technology in regenerative medicine for limb salvage. It is also developing immunotherapies for ovarian cancer, pancreatic cancer, and mesothelioma. The company was formerly known as H-CYTE, Inc. and changed its name to Innoveren Scientific Inc. in July 2023. The company is headquartered in Tampa, Florida.
Innoveren Scientific Inc. (IVRN) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2023: 0.030x
Based on the latest financial reports, Innoveren Scientific Inc. (IVRN) has a cash flow conversion efficiency ratio of 0.030x as of September 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-325.98K) by net assets ($-10.89 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Innoveren Scientific Inc. - Cash Flow Conversion Efficiency Trend (2019–2022)
This chart illustrates how Innoveren Scientific Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Innoveren Scientific Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Innoveren Scientific Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
EASTFIELD RES
BE:35E
|
0.009x |
|
DFNN Inc
PSE:DFNN
|
0.083x |
|
PT Medela Potentia Tbk
JK:MDLA
|
0.053x |
|
KWG PROPERTY (KOU.SG)
STU:KOU
|
N/A |
|
Unicap Modaraba
KAR:UCAPM
|
N/A |
|
W.A.G payment solutions plc
LSE:EWG
|
0.322x |
|
CVR Medical Corp
STU:B3BN
|
0.035x |
|
Brite-Strike Tactical Illumination Products Inc
PINK:BSTK
|
0.314x |
Annual Cash Flow Conversion Efficiency for Innoveren Scientific Inc. (2019–2022)
The table below shows the annual cash flow conversion efficiency of Innoveren Scientific Inc. from 2019 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | $-9.36 Million | $-1.91 Million | 0.205x | -80.18% |
| 2021-12-31 | $-4.66 Million | $-4.81 Million | 1.032x | -85.11% |
| 2020-12-31 | $-1.05 Million | $-7.26 Million | 6.926x | +91.61% |
| 2019-12-31 | $-3.40 Million | $-12.29 Million | 3.615x | -- |